NEPHROGENIC ANAEMIA side effect
What is NEPHROGENIC ANAEMIA ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
NEPHROGENIC ANAEMIA and Recently Reported Side Effects
NEPHROGENIC ANAEMIA and 15 most Active Side Effect polls
NEPHROGENIC ANAEMIA and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with NEPHROGENIC ANAEMIA
ARANESP ATORVASTATIN CIPROFLOXACIN DIOVAN ENDOXAN HUMALOG LAMIVUDINE MICARDIS OLMETEC OMNISCAN PROGRAF ZEMPLAREndoxan Side Effects Report #5670268-2
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on Mar 07, 2008. Female patient, 88 years of age, was diagnosed with lymphoma and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: nephrogenic anaemia, renal impairment, . ENDOXAN dosage: unknown. During the same period patient was treated with DOXORUBICIN, VINCRISTINE SULPHATE, PREDNISOLONE, RITUXIMAB. Patient recovered.
Endoxan Side Effects Report #5674149-X
ENDOXAN problem was reported by a Consumer or non-health professional from JAPAN on Mar 10, 2008. Female patient, 88 years of age, was diagnosed with lymphoma and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: nephrogenic anaemia, renal impairment, . ENDOXAN dosage: unknown. During the same period patient was treated with DOXORUBICIN, VINCRISTINE SULPHATE, PREDNISOLONE, RITUXIMAB. Patient recovered.
Micardis Side Effects Report #5680745-6
Consumer or non-health professional from JAPAN reported MICARDIS problem on Mar 24, 2008. Male patient, weighting 119.0 lb, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: nephrogenic anaemia, renal failure chronic, . MICARDIS dosage: unknown. During the same period patient was treated with NORVASC. Patient recovered.
Atorvastatin Side Effects Report #5643366-7
ATORVASTATIN problem was reported by a Health Professional from SPAIN on Feb 20, 2008. Male patient, weighting 158.7 lb, was diagnosed with acute coronary syndrome and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: nephrogenic anaemia, . ATORVASTATIN dosage: unknown. During the same period patient was treated with CLOPIDOGREL, ASA HIGH DOSE. Patient was hospitalized. Patient recovered.
Prograf Side Effects Report #5595985-4
Physician from GERMANY reported PROGRAF problem on Jan 10, 2008. Male patient, weighting 143.3 lb, was diagnosed with prophylaxis against transplant rejection and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: nephrogenic anaemia, renal failure, . PROGRAF dosage: unknown. During the same period patient was treated with RAPAMUNE, CELLCEPT. Patient was hospitalized. Patient recovered.
Prograf Side Effects Report #5563273-8
PROGRAF problem was reported by a Physician from GERMANY on Dec 10, 2007. Male patient, weighting 141.1 lb, was diagnosed with prophylaxis against transplant rejection and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: nephrogenic anaemia, renal failure, . PROGRAF dosage: unknown. During the same period patient was treated with RAPAMUNE, CELLCEPT. Patient was hospitalized. Patient recovered.
Atorvastatin Side Effects Report #5563319-7
Health Professional from SPAIN reported ATORVASTATIN problem on Dec 10, 2007. Male patient, weighting 158.7 lb, was diagnosed with acute coronary syndrome and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: nephrogenic anaemia, . ATORVASTATIN dosage: unknown. During the same period patient was treated with CLOPIDOGREL, ASA HIGH DOSE. Patient was hospitalized. Patient recovered.
Diovan Side Effects Report #5503802-3
DIOVAN problem was reported by a Physician from on Oct 23, 2007. Female patient, 82 years of age, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: nephrogenic anaemia, . DIOVAN dosage: 80 MG DAILY. During the same period patient was treated with NORVASC, TENORMIN. Patient was hospitalized. Patient recovered.
Atorvastatin Side Effects Report #5497965-6
Health Professional from SPAIN reported ATORVASTATIN problem on Oct 15, 2007. Male patient, weighting 158.7 lb, was diagnosed with acute coronary syndrome and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: nephrogenic anaemia, . ATORVASTATIN dosage: unknown. During the same period patient was treated with ASA HIGH DOSE, CLOPIDOGREL. Patient recovered.
Prograf Side Effects Report #5755421-1
PROGRAF problem was reported by a Physician from GERMANY on May 29, 2008. Male patient, weighting 160.9 lb, was diagnosed with prophylaxis against transplant rejection and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: nephrogenic anaemia, renal failure, . PROGRAF dosage: unknown. During the same period patient was treated with RAPAMUNE, CELLCEPT. Patient was hospitalized. Patient recovered.
Humalog Side Effects Report #5756981-7
Physician from JAPAN reported HUMALOG problem on May 23, 2008. Female patient, weighting 70.77 lb, was diagnosed with type 2 diabetes mellitus, hypertension, oedema and was treated with HUMALOG. After drug was administered, patient experienced the following problems/side effects: nephrogenic anaemia, renal failure, . HUMALOG dosage: unknown. During the same period patient was treated with MICARDIS, FUROSEMIDE, SPIRONOLACTONE. Patient recovered.
Prograf Side Effects Report #5735835-6
PROGRAF problem was reported by a Physician from GERMANY on May 05, 2008. Male patient, weighting 160.9 lb, was diagnosed with prophylaxis against transplant rejection and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: nephrogenic anaemia, renal failure, . PROGRAF dosage: unknown. During the same period patient was treated with RAPAMUNE, CELLCEPT. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5728504-X
Physician from GERMANY reported ARANESP problem on Apr 23, 2008. Male patient, weighting 183.0 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: aplasia pure red cell, nephrogenic anaemia, . ARANESP dosage: unknown. During the same period patient was treated with NESPO, ACTRAPHANE, ASPIRIN, METOPROLOL TARTRATE, CALCIUM ACETATE, FERRLECIT. Patient recovered.
Zemplar Side Effects Report #5747678-8
ZEMPLAR problem was reported by a Consumer or non-health professional from GERMANY on May 14, 2008. Male patient, 51 years of age, weighting 205.0 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: myocardial infarction, nephrogenic anaemia, pre-existing disease, . ZEMPLAR dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, CLOPIDOGREL BISULPHATE, CANDESARTAN CILEXETIL, CARVEDILOL, ALUMINIUM CHLORHYDROXIDE. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5702361-X
Physician from GERMANY reported ARANESP problem on Mar 31, 2008. Male patient, weighting 183.0 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: aplasia pure red cell, nephrogenic anaemia, . ARANESP dosage: unknown. During the same period patient was treated with ACTRAPHANE, ASPIRIN, METOPROLOL TARTRATE, CALCIUM ACETATE, FERRLECIT. Patient recovered.
Omniscan Side Effects Report #5567576-2
OMNISCAN problem was reported by a Consumer or non-health professional from JAPAN on Dec 05, 2007. Male patient, 14 years of age, was diagnosed with glaucoma and was treated with OMNISCAN. After drug was administered, patient experienced the following problems/side effects: azotaemia, eye excision, nephrogenic anaemia, nephrogenic systemic fibrosis, renal osteodystrophy, . OMNISCAN dosage: 10 ML, SINGLE DOSE, I.V.. During the same period patient was treated with EPOETIN, FAMOTIDINE, CEFMETAZOLE, PENTAZOCINE, ALFACALCIDOL, FERROUS CITRATE, ALLOPURINOL, AMLODIPINE BESYLATE. Patient was hospitalized and became disabled. Patient recovered.
Omniscan Side Effects Report #5480222-1
Physician from JAPAN reported OMNISCAN problem on Sept 25, 2007. Male patient, 14 years of age, was diagnosed with glaucoma, retinal neoplasm and was treated with OMNISCAN. After drug was administered, patient experienced the following problems/side effects: azotaemia, eye excision, nephrogenic anaemia, nephrogenic systemic fibrosis, pyrexia, renal osteodystrophy, . OMNISCAN dosage: unknown. During the same period patient was treated with EPOETIN, FAMOTIDINE, CEFMETAZOLE. Patient was hospitalized and became disabled. Patient recovered.
Diovan Side Effects Report #5469799-X
DIOVAN problem was reported by a Physician from on Sept 20, 2007. Female patient, 82 years of age, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: cerebral infarction, hemiplegia, nephrogenic anaemia, . DIOVAN dosage: 80 MG DAILY. During the same period patient was treated with NORVASC, TENORMIN. Patient was hospitalized. Patient recovered.
Lamivudine Side Effects Report #5402690-3
Physician from JAPAN reported LAMIVUDINE problem on July 30, 2007. Male patient, 49 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus, hypertension, nephrogenic anaemia, nephropathy, renal disorder, renal failure, . LAMIVUDINE dosage: 150MG TWICE PER DAY. During the same period patient was treated with ZERIT, CRIXIVAN, VIRACEPT, ZIAGEN. Patient was hospitalized and became disabled. Patient recovered.
Lamivudine Side Effects Report #5380787-4
LAMIVUDINE problem was reported by a Physician from JAPAN on June 29, 2007. Male patient, 49 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus, hypertension, nephrogenic anaemia, nephropathy, renal disorder, renal failure, . LAMIVUDINE dosage: 150MG TWICE PER DAY. During the same period patient was treated with ZERIT, CRIXIVAN, VIRACEPT, ZIAGEN. Patient recovered.
Lamivudine Side Effects Report #5380787-4
Physician from JAPAN reported LAMIVUDINE problem on June 29, 2007. Male patient, 49 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus, hypertension, nephrogenic anaemia, nephropathy, renal disorder, renal failure, . LAMIVUDINE dosage: 150MG TWICE PER DAY. During the same period patient was treated with ZERIT, CRIXIVAN, VIRACEPT, ZIAGEN. Patient recovered.
Ciprofloxacin Side Effects Report #5756667-9
CIPROFLOXACIN problem was reported by a Physician from ITALY on May 20, 2008. Male patient, 64 years of age, was diagnosed with respiratory tract infection, urinary tract infection, hypertension and was treated with CIPROFLOXACIN. After drug was administered, patient experienced the following problems/side effects: hepatitis acute, multi-organ failure, nephrogenic anaemia, renal failure acute, . CIPROFLOXACIN dosage: UNIT DOSE: 500 MG. During the same period patient was treated with CLEXANE, AMPICILLIN, ROCEPHIN, TENORMIN, NORVASC. Patient died on 02/03/2008.
Olmetec Side Effects Report #5283152-3
Physician from JAPAN reported OLMETEC problem on Mar 12, 2007. Female patient, 37 years of age, was diagnosed with hypertension and was treated with OLMETEC. After drug was administered, patient experienced the following problems/side effects: condition aggravated, lymphocyte stimulation test positive, nephrogenic anaemia, uterine leiomyoma, . OLMETEC dosage: 20 MG QD PO. During the same period patient was treated with AMLODIN, LASIX, CALBLOCK, CARDENALIN, SURULAC S. Patient was hospitalized. Patient recovered.